Receive the latest national-international updates in your inbox

You’ve probably heard about the cost of the life-saving Epipen skyrocketing. Now the drug maker is promising discounts, but they’re not the only manufacturer in town. There’s also a cheaper alternative. Roseanne Colletti reports. (Published Thursday, Aug. 25, 2016)

Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has soared over the past decade.

But the drugmaker didn't budge on its price hikes Thursday, which have drawn ire both in Congress and from families that have had to shell out increasingly large sums for the potentially life-saving treatment.

Mylan joins a growing list of drugmakers, Turing Pharmaceuticals and Valeant Pharmaceuticals International Inc. among them, that have been called out after mammoth price hikes for the drugs they sell, with little or no innovation.

Turing's former CEO Martin Shkreli became the poster child of pharmaceutical-industry greed last fall for hiking the price of a life-saving drug, Daraprim, by more than 5,000 percent.

The average price of a two-dose EpiPen package climbed to about $608 earlier this year, up more than 500 percent from around $94 nine years ago, according to the Elsevier Clinical Solutions' Gold Standard Drug Database.

Suspect in Georgia Officer Shooting Dead

Authorities announced the death of Minquell Kennedy Lembrick, 32, on Dec. 8, 2016 after a manhunt stemming from a domestic abuse call at an Americus, Georgia apartment. (Published Thursday, Dec. 8, 2016)

Mylan CEO Heather Bresch told CNBC Thursday that lowering the price was not an option.

"Had we reduced the list price, I couldn't ensure that everyone who needs an EpiPen gets one," she said.

EpiPens are used in emergencies to treat severe allergies that can lead to anaphylactic shock. Roughly 40 million Americans have severe allergies to spider bites, bee stings and foods like nuts, eggs and shellfish.

Democratic presidential candidate Hillary Clinton and members of Congress from both parties have quickly ramped up criticism of the price Mylan charges for the medicine.

Clinton said Wednesday that pharmaceutical and biotech industries can fuel American innovation, and combat debilitating diseases. But she added that "it's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them."

Bresch said Thursday that Mylan gets $274 for a two-dose EpiPen package. The rest of the $608 price goes to entities that stand between the drugmaker and the patient, like insurers, pharmacy benefits managers, wholesalers and drugstores.

Mylan said Thursday that it was doubling the eligibility for its patient assistance program to people with incomes four times higher than the federal poverty level. It said that means a family of four making up to $97,200 would pay nothing out of pocket for the treatment. It also noted that its $300 savings card would cut the bill in half for patients who would otherwise have to pay full price for the EpiPen.

Patients also will be able to order the injected medicine directly from the company, to help lower costs.

Watch: Senators Pay Tribute to Joe Biden With Speeches

Vice President Joe Biden was honored with an emotional bi-partisan tribute on the Senate chamber floor on Dec. 7. 2016. Senators on both sides of the aisle were on the same page as they stepped up to express their admiration and gratitude to the outgoing vice president. An emotional Biden sat in the presiding chair during the moving tribute, which latest for more than two hours as lawmakers celebrated their colleague. (Published Thursday, Dec. 8, 2016)

These measures could provide significant help for people with no coverage facing the full bill. But they might have more limited value to a patient whose insurer will cover most of the bill anyway and whose future premium could be affected by the drug's price.

Customers of Express Scripts Holding Co., the nation's largest pharmacy benefits manager, pay about $73.50 out of pocket for an EpiPen prescription, spokesman Brian Henry said. He noted that price has stayed relatively stable the past couple years.